These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. Yokoi S; Yasui K; Saito-Ohara F; Koshikawa K; Iizasa T; Fujisawa T; Terasaki T; Horii A; Takahashi T; Hirohashi S; Inazawa J Am J Pathol; 2002 Jul; 161(1):207-16. PubMed ID: 12107105 [TBL] [Abstract][Full Text] [Related]
3. Amplification and overexpression of SKP2 are associated with metastasis of non-small-cell lung cancers to lymph nodes. Yokoi S; Yasui K; Mori M; Iizasa T; Fujisawa T; Inazawa J Am J Pathol; 2004 Jul; 165(1):175-80. PubMed ID: 15215173 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of S-phase kinase associated protein 2 (Skp2) induces apoptosis in oral cancer cells. Harada K; Supriatno ; Kawashima Y; Itashiki Y; Yoshida H; Sato M Oral Oncol; 2005 Jul; 41(6):623-30. PubMed ID: 16050017 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells. Lee SH; McCormick F J Mol Med (Berl); 2005 Apr; 83(4):296-307. PubMed ID: 15605273 [TBL] [Abstract][Full Text] [Related]
6. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells. Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389 [TBL] [Abstract][Full Text] [Related]
7. SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation. Li Z; Huang J; Yuan H; Chen Z; Luo Q; Lu S Oncotarget; 2016 Apr; 7(14):18927-39. PubMed ID: 26942878 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells. Lin R; Wang TT; Miller WH; White JH Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749 [TBL] [Abstract][Full Text] [Related]
9. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer. Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027 [TBL] [Abstract][Full Text] [Related]
10. The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells. Lu L; Schulz H; Wolf DA BMC Cell Biol; 2002 Aug; 3():22. PubMed ID: 12188931 [TBL] [Abstract][Full Text] [Related]
11. Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer. Pavlides SC; Huang KT; Reid DA; Wu L; Blank SV; Mittal K; Guo L; Rothenberg E; Rueda B; Cardozo T; Gold LI Endocrinology; 2013 Nov; 154(11):4030-45. PubMed ID: 24035998 [TBL] [Abstract][Full Text] [Related]
12. Bortezomib-mediated expression of p27Kip1 through S-phase kinase protein 2 degradation in epithelial ovarian cancer. Uddin S; Ahmed M; Hussain AR; Jehan Z; Al-Dayel F; Munkarah A; Bavi P; Al-Kuraya KS Lab Invest; 2009 Oct; 89(10):1115-27. PubMed ID: 19636294 [TBL] [Abstract][Full Text] [Related]
13. Targeted pharmacologic inhibition of S-phase kinase-associated protein 2 (SKP2) mediated cell cycle regulation in lung and other RB-Related cancers: A brief review of current status and future prospects. Elahi AH; Morales CS; Xu XL; Eliades A; Patsalis PC; Abramson DH; Jhanwar SC Adv Biol Regul; 2023 May; 88():100964. PubMed ID: 37004354 [TBL] [Abstract][Full Text] [Related]
14. Protective function of p27(KIP1) against apoptosis in small cell lung cancer cells in unfavorable microenvironments. Masuda A; Osada H; Yatabe Y; Kozaki K; Tatematsu Y; Takahashi T; Hida T; Takahashi T; Takahashi T Am J Pathol; 2001 Jan; 158(1):87-96. PubMed ID: 11141482 [TBL] [Abstract][Full Text] [Related]
15. p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligase. Li P; Li C; Zhao X; Zhang X; Nicosia SV; Bai W J Biol Chem; 2004 Jun; 279(24):25260-7. PubMed ID: 15075339 [TBL] [Abstract][Full Text] [Related]
16. Sulforaphane down-regulates SKP2 to stabilize p27(KIP1) for inducing antiproliferation in human colon adenocarcinoma cells. Chung YK; Chi-Hung Or R; Lu CH; Ouyang WT; Yang SY; Chang CC J Biosci Bioeng; 2015 Jan; 119(1):35-42. PubMed ID: 25070589 [TBL] [Abstract][Full Text] [Related]
17. Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation. Kudo Y; Kitajima S; Ogawa I; Kitagawa M; Miyauchi M; Takata T Mol Cancer Ther; 2005 Mar; 4(3):471-6. PubMed ID: 15767556 [TBL] [Abstract][Full Text] [Related]
18. Estrogens down-regulate p27Kip1 in breast cancer cells through Skp2 and through nuclear export mediated by the ERK pathway. Foster JS; Fernando RI; Ishida N; Nakayama KI; Wimalasena J J Biol Chem; 2003 Oct; 278(42):41355-66. PubMed ID: 12904306 [TBL] [Abstract][Full Text] [Related]
19. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer. Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165 [TBL] [Abstract][Full Text] [Related]
20. Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163. Su L; Han D; Wu J; Huo X Tumour Biol; 2016 Mar; 37(3):3925-31. PubMed ID: 26482610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]